|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
D
|
|
INDICATIONS:
|
|
Septicemia, neonatal |
|
Burns |
|
Infection, bone |
|
Infection, central nervous system |
|
Infection, intra- abdominal |
|
Infection, joint |
|
Infection, postoperative |
|
Infection, respiratory tract |
|
Infection, skin and skin structure |
|
Infection, urinary tract |
|
Peritonitis |
|
Septicemia |
| |
|
|
SIDE EFFECTS:
|
|
azotemia |
|
cylindruria |
|
dizziness |
|
hearing loss |
|
hyposthenuria |
|
injection site reaction |
|
myasthenia |
|
proteinuria |
|
pyuria |
|
renal tubular acidosis |
|
renal tubular necrosis |
|
tinnitus |
|
vertigo |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
botulism |
|
breast-feeding |
|
dehydration |
|
elderly |
|
hearing impairment |
|
myasthenia gravis |
|
neonates |
|
parkinsonism |
|
pregnancy |
|
renal disease |
|
|
ADULT DOSE:
|
|
Antibacterial(systemic)-Intramuscular or intravenous infusion, 5 mg per kg of body weight every eight hours; or 7.5 mg per kg of body weight every twelve hours for seven to ten days.
Note: Urinary tract infections, bacterial (uncomplicated)-Intramuscular or intravenous infusion, 250 mg every twelve hours.
Following hemodialysis, a supplemental dose of 3 to 5 mg per kg of body weight may be administered. |
|
MAXIMUM ADULT DOSE:
|
|
Up to 15 mg per kg of body weight daily, but not to exceed 1.5 grams daily for more than ten days.
|
|
PEDIATRIC DOSE:
|
|
Antibacterial(systemic):-Intramuscular or intravenous infusion- Premature neonates:
-Initially, 10 mg per kg of body weight, then 7.5 mg per kg of body weight every eighteen to twenty-four hours for seven to ten days.
Neonates:
-Initially, 10 mg per kg of body weight, then 7.5 mg per kg of body weight every twelve hours for seven to ten days.
Older infants and children:
See Usual adult and adolescent dose. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|